Videos

Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how cancer care has changed over the years.

Oncologists Have Feelings Too: Navigating the Patient Physician Relationship

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about how patients can better understand the emotions their oncologists may be going through during treatment.

Debunking Myths of Clinical Trials for Cancer

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about clinical trials in cancer care.

Highlighting Geographic, Economic Disparities in Cancer Care

January 31st 2023

Jumping Through Insurance Hoops for Treatment

January 31st 2023

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about the challenges patients and physicians face with insurance matters during cancer care.

Aimee's Dad

January 31st 2023

Donna's Story

January 31st 2023

SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

January 24th 2023

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

‘Profound’ Evidence Shows Breathing Can Improve Cancer-Related Pain and Stress

January 17th 2023

While some may say that teaching breathing techniques gives patients with cancer the “heebie-jeebies”, it can actually have a major impact on patients’ pain and stress, according to an expert.

MF Progression to Acute Myeloid Leukemia and Subsequent Treatment

January 12th 2023

Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.

Myelofibrosis: Novel Treatment Strategies and Combination Therapies

January 5th 2023

Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.

Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera

January 5th 2023

Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.

Adverse Events Tied to Treatment for Myeloproliferative Neoplasms

December 29th 2022

Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.

Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms

December 29th 2022

Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.

Educated Patient Webinar: An Insightful Look at Advanced GIST and Available Treatment Options

December 23rd 2022

Overview of Treatment Options for Myelofibrosis

December 22nd 2022

Switching their focus to myelofibrosis, Rami Komrokji, MD, and Ruben Mesa, MD, consider mainstay treatment options in this setting.

Overview on the Management of Essential Thrombocythemia and Polycythemia Vera

December 22nd 2022

Centering their discussion on cornerstone therapies, expert hematologist-oncologists consider the treatment paradigms of essential thrombocythemia and polycythemia vera.

Educated Patient® MPN Summit Myelofibrosis Panel: November 19, 2022

December 18th 2022

Watch Dr. Aaron Gerds and Dr. Andrew Kuykendall answer questions about myelofibrosis during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Myelofibrosis Second-Line Treatment and Beyond Presentation: November 19, 2022

December 17th 2022

Watch Dr. Andrew Kuykendall, from the Mofitt Cancer Center, discuss second-line treatments and beyond for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

Educated Patient® MPN Summit First-line Treatment in Myelofibrosis Presentation: November 19, 2022

December 16th 2022

Watch to Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, discuss frontline treatment options for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

How Are Myeloproliferative Neoplasms Diagnosed?

December 15th 2022

Key opinion leaders highlight different testing and workup methods involved in making an accurate diagnosis of myeloproliferative neoplasms.

A Background on Myeloproliferative Neoplasms

December 15th 2022

Experts Rami Komrokji, MD, and Ruben Mesa, MD, define myeloproliferative neoplasms (MPNs) and explain differences between essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).

Educated Patient® MPN Summit Polycythemia Vera Panel: November 19, 2022

December 15th 2022

Watch Dr. Jamile Shammo and Dr. John Mascarenhas answer questions about polycythemia vera during the CURE Educated Patient MPN Summit.

Ongoing Research May Lead to ‘Exciting’ Advancements for Myelofibrosis Years Down the Line

December 14th 2022

Research efforts will improve the lives of patients with myelofibrosis, though those advancements may take years to come, an expert said.

Educated Patient® MPN Summit Future Treatment of Polycythemia Vera Presentation: November 19, 2022

December 14th 2022

Watch Dr. John Mascarenhas, from the Icahn School of Medicine at Mount Sinai, discuss future treatments for polycythemia vera, during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Current Treatment Options in Polycythemia Vera Presentation: November 19, 2022

December 13th 2022

Watch Dr. Jamile M. Shammo, from Northwestern University Feinberg School of Medicine, discuss current treatment options in polycythemia vera during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Essential Thrombocythemia Panel: November 19, 2022

December 12th 2022

Watch Dr. Aaron Gerds and Dr. Douglas Tremblay answer questions about essential thrombocythemia during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Current and Future Treatments of Essential Thrombocythemia Presentation: November 19, 2022

December 11th 2022

Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Defining Essential Thrombocythemia Risk Presentation: November 19, 2022

December 10th 2022

Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.

Educated Patient® Webinar: GI Cancers Series Part 3: Immunotherapy and Targeted Therapy in GI Cancers

December 9th 2022